Cryo vs RF Efficacy Model (AF Ablation) Calculator

Clinical calculation support · Verify results before clinical use

Patient Profile

Enter pre-ablation clinical and echocardiographic variables to calculate the APPLE score.

— APPLE
APPLE point if age is greater than 65 years.
Persistent AF contributes one APPLE point.
APPLE point if diameter is 43 mm or greater.
APPLE point if eGFR is below 60 mL/min/1.73 m².
APPLE point if LVEF is below 50%.
Reset calculator

Clinical context and limitations

The APPLE score is a five-item score developed to estimate the likelihood of atrial arrhythmia recurrence after catheter ablation. It assigns one point for each of the following: age greater than 65 years, persistent AF, eGFR below 60 mL/min/1.73 m², left atrial diameter at least 43 mm, and LVEF below 50%.

How to interpret this calculator

  • The APPLE score is a risk-stratification aid; its discrimination in the original study was modest (AUC approximately 0.63), so it should not be used as a stand-alone decision rule.
  • The recurrence percentages retained from the original code are fixed cohort-level approximations. They are not individualized probabilities and have not been recalibrated to a local population, ablation platform, monitoring protocol, or contemporary endpoint.
  • The original code assigns the same predicted outcome to Cryo and RF by setting the relative risk to 1.00. This is an assumption in the calculator, not a patient-specific comparative-effectiveness calculation.
  • FIRE AND ICE demonstrated noninferiority for cryoballoon versus radiofrequency ablation in patients with paroxysmal AF. Do not use that trial alone to claim equivalent outcomes for persistent AF.
  • Selection of ablation technology should consider AF phenotype, anatomy, procedural safety, operator and centre experience, and patient preferences.

APPLE score components

ComponentCriterionPoints
Age>65 years1
Persistent AFPersistent AF phenotype1
Impaired renal functioneGFR <60 mL/min/1.73 m²1
Left atrial diameter≥43 mm1
Left ventricular functionLVEF <50%1

References

Kornej J, et al. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015. PubMed record

Source for the five APPLE components and external validation; reported predictive discrimination was modest.

Kuck KH, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation (FIRE AND ICE). N Engl J Med. 2016;374:2235–2245. doi:10.1056/NEJMoa1602014

Randomized trial showing noninferiority for the specified efficacy endpoint in paroxysmal AF.

Clinical disclaimer: This tool is intended for educational and decision-support use. Risk scores and cohort-derived percentages do not replace individualized clinical assessment or shared decision-making. The model does not provide a validated head-to-head estimate of cryoballoon versus radiofrequency efficacy for an individual patient.